Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / cue health to announce fourth quarter and full year


HLTH - Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results

Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here . Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com . A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Cue Health

Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cue’s customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 test, which became the first home use respiratory test to receive this FDA approval. Cue also received Emergency Use Authorization from the FDA for its molecular Mpox test at the point-of-care and, to expand its test menu, the company has a number of other submissions under review by the FDA. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20240228029129/en/

Press
Cue Health
press@cuehealth.com

Investors
ICR Westwicke
Caroline Corner
+1-415-202-5678
caroline.corner@westwicke.com

Stock Information

Company Name: Cue Health Inc.
Stock Symbol: HLTH
Market: NYSE
Website: nobilishealth.com

Menu

HLTH HLTH Quote HLTH Short HLTH News HLTH Articles HLTH Message Board
Get HLTH Alerts

News, Short Squeeze, Breakout and More Instantly...